Literature DB >> 18382725

From fatty streak to fatty liver: 33 years of joint publications in the JCI.

Joseph L Goldstein1, Michael S Brown.   

Abstract

The ASCI is notable for two unique functions--the annual meeting and The Journal of Clinical Investigation. Both have inspired us over the 37 years of our collaborative adventures in research. In this retrospective, we review highlights from our 26 joint papers in the JCI, focusing on two papers that revealed the consequences of lipid accumulation with implications for atherosclerosis and steatohepatitis.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18382725      PMCID： PMC2276798          DOI： 10.1172/JCI34973

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


  18 in total

Review 1.  SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver.

Authors:  Jay D Horton; Joseph L Goldstein; Michael S Brown
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

Review 2.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

3.  Role of the low density lipoprotein receptor in regulating the content of free and esterified cholesterol in human fibroblasts.

Authors:  M S Brown; J R Faust; J L Goldstein
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

Review 4.  The clinical investigator: bewitched, bothered, and bewildered--but still beloved.

Authors:  J L Goldstein; M S Brown
Journal:  J Clin Invest       Date:  1997-06-15       Impact factor: 14.808

Review 5.  Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis.

Authors:  M S Brown; J L Goldstein
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

Review 6.  Molecular mediators of hepatic steatosis and liver injury.

Authors:  Jeffrey D Browning; Jay D Horton
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

7.  Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a.

Authors:  H Shimano; J D Horton; R E Hammer; I Shimomura; M S Brown; J L Goldstein
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

8.  Lipid droplets in atherosclerotic fatty streaks of human aorta.

Authors:  P D Lang; W Insull
Journal:  J Clin Invest       Date:  1970-08       Impact factor: 14.808

9.  SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis.

Authors:  X Wang; R Sato; M S Brown; X Hua; J L Goldstein
Journal:  Cell       Date:  1994-04-08       Impact factor: 41.582

10.  Familial hypercholesterolemia: defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity.

Authors:  M S Brown; J L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1974-03       Impact factor: 11.205
View more
  13 in total

Review 1.  A history of the American Society for Clinical Investigation.

Authors:  Joel D Howell
Journal:  J Clin Invest       Date:  2009-04       Impact factor: 14.808

2.  Identification of genes whose expression is altered by obesity throughout the arterial tree.

Authors:  Jaume Padilla; Nathan T Jenkins; Pamela K Thorne; Jeffrey S Martin; R Scott Rector; J Wade Davis; M Harold Laughlin
Journal:  Physiol Genomics       Date:  2014-09-30       Impact factor: 3.107

3.  AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice.

Authors:  Yu Li; Shanqin Xu; Maria M Mihaylova; Bin Zheng; Xiuyun Hou; Bingbing Jiang; Ogyi Park; Zhijun Luo; Etienne Lefai; John Y-J Shyy; Bin Gao; Michel Wierzbicki; Tony J Verbeuren; Reuben J Shaw; Richard A Cohen; Mengwei Zang
Journal:  Cell Metab       Date:  2011-04-06       Impact factor: 27.287

Review 4.  Targeting SREBP-1-driven lipid metabolism to treat cancer.

Authors:  Deliang Guo; Erica Hlavin Bell; Paul Mischel; Arnab Chakravarti
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

5.  EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapy.

Authors:  Deliang Guo; Robert M Prins; Julie Dang; Daisuke Kuga; Akio Iwanami; Horacio Soto; Kelly Y Lin; Tiffany T Huang; David Akhavan; M Benjamin Hock; Shaojun Zhu; Ava A Kofman; Steve J Bensinger; William H Yong; Harry V Vinters; Steve Horvath; Andrew D Watson; John G Kuhn; H Ian Robins; Minesh P Mehta; Patrick Y Wen; Lisa M DeAngelis; Michael D Prados; Ingo K Mellinghoff; Timothy F Cloughesy; Paul S Mischel
Journal:  Sci Signal       Date:  2009-12-15       Impact factor: 8.192

Review 6.  The neuropsychiatric translational revolution: still very early and still very challenging.

Authors:  Lara Braff; David L Braff
Journal:  JAMA Psychiatry       Date:  2013-08       Impact factor: 21.596

7.  Activation of sterol regulatory element binding protein and NLRP3 inflammasome in atherosclerotic lesion development in diabetic pigs.

Authors:  Yu Li; Shanqin Xu; Bingbing Jiang; Richard A Cohen; Mengwei Zang
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

8.  Liver-specific NG37 overexpression leads to diet-dependent fatty liver disease accompanied by cardiac dysfunction.

Authors:  Xin Zhou; MengMeng Xu; Liyang Wang; Yulian Mu; Rui Feng; Zhilong Dong; Yuexin Pan; Xunzhang Chen; Yongfeng Liu; Shangen Zheng; Donald D Anthony; Jianjie Ma; Williams B Isaacs; Xuehong Xu
Journal:  Genes Nutr       Date:  2016-05-21       Impact factor: 5.523

9.  Characterization of tubular liquid crystal structure in embryonic stem cell derived embryoid bodies.

Authors:  MengMeng Xu; Odell D Jones; Liyang Wang; Xin Zhou; Harry G Davis; Joseph L Bryant; Jianjie Ma; Willian B Isaacs; Xuehong Xu
Journal:  Cell Biosci       Date:  2017-01-03       Impact factor: 7.133

10.  Old and rising stars in the lymphoid liver.

Authors:  Carlo Selmi; Mauro Podda; M Eric Gershwin
Journal:  Semin Immunopathol       Date:  2009-07-15       Impact factor: 9.623
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.